WENDY VERANO: Open Payments
NPI 1669550802 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$144 in 6 payments from 3 companies in 2025. Trend: 2023 $444 · 2024 $325 · 2025 $144
Food & beverage: $144
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
Products named: XIFAXAN, SKYRIZI, ENTYVIO, VIBERZI, LINZESS.
Industry payments across CA — which companies pay providers there.
